Volume 154, Issue 6, Pages (December 2018)

Slides:



Advertisements
Similar presentations
Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.
Advertisements

Effects of Rivaroxaban Versus Warfarin on Hospitalization Days and Other Health Care Resource Utilization in Patients With Nonvalvular Atrial Fibrillation:
Volume 149, Issue 5, Pages (May 2016)
Volume 151, Issue 1, Pages (January 2017)
Quality of Life in Long-term Survivors of Acute Pulmonary Embolism
Volume 149, Issue 6, Pages (June 2016)
Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  James A. Stone, MD,
Volume 130, Issue 6, Pages (December 2006)
The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting.
Volume 120, Issue 6, Pages (December 2001)
Wan-Jie Gu, MSc, Chun-Yin Wei, MSc, Rui-Xing Yin, MD, PhD  CHEST 
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Volume 151, Issue 4, Pages (April 2017)
Volume 146, Issue 6, Pages (December 2014)
Volume 144, Issue 3, Pages (September 2013)
Volume 143, Issue 1, Pages (January 2013)
Volume 151, Issue 3, Pages (March 2017)
Venous Thrombosis After Electrophysiology Procedures
Volume 152, Issue 5, Pages (November 2017)
Comparative Safety of Drugs Targeting the Nitric Oxide Pathway in Pulmonary Hypertension  Charles Khouri, PharmD, Marion Lepelley, PharmD, Matthieu Roustit,
Hospital Volume and Outcomes of Robot-Assisted Lobectomies
Extended Treatment of VTE: Who is the Right Candidate?
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis by Paolo Prandoni,
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use by Ida Martinelli, Anthonie W. A. Lensing, Saskia.
Volume 153, Issue 1, Pages (January 2018)
Robert M. Jacobson, MD, George J. Isham, MD, MS, Lila J
The Therapeutic Potential of Hyaluronan in COPD
Volume 153, Issue 4, Pages (April 2018)
Volume 150, Issue 3, Pages (September 2016)
Volume 153, Issue 5, Pages (May 2018)
Volume 153, Issue 5, Pages (May 2018)
The Effect of Alcohol Consumption on the Risk of ARDS
Timing the First Postoperative Dose of Anticoagulants
New Oral Anticoagulants and VTE Management
A 15-Year-Old Boy with Mysterious Variability in Apnea-Hypopnea Index
Timing the First Postoperative Dose of Anticoagulants
Probiotics for Prevention of Ventilator-Associated Pneumonia: Response
Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH  Heart Rhythm 
Has the 6-Min Walk Distance Run Its Course?
Extending Treatment for Thrombosis: What’s the Right Choice?
Practical Considerations to Extend Treatment for VTE
Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH  Heart Rhythm 
Volume 151, Issue 2, Pages (February 2017)
A Multidisciplinary Pulmonary Embolism Response Team
Antithrombotic Therapy for VTE Disease
The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective  Gregorio T. Obrador, MD, MPH, Ximena Rubilar,
A 77-Year-Old Woman With Acute Shortness of Breath and Chest Pain
Volume 152, Issue 6, Pages (December 2017)
Sevelamer Prescriptions After Reporting of the Dialysis Clinical Outcomes Revisited (DCOR) Trial Findings: An Analysis of 5,495 Patients Receiving Maintenance.
An Elderly Man With Dyspnea and Chest Pain
Volume 152, Issue 4, Pages (October 2017)
Weekday and Survival After Pulmonary Resections for Lung Cancer
Idiopathic Pulmonary Arterial Hypertension in Asians
Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding
Volume 143, Issue 1, Pages (January 2013)
Imaging for the Management of Community-Acquired Pneumonia
Managing Pulmonary Embolism Posthospital Discharge
Volume 155, Issue 4, Pages (April 2019)
Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline  J Noble,
Volume 154, Issue 5, Pages (November 2018)
A Patient With Chest Pain and Hyperacute T Waves
Therapy for Pulmonary Arterial Hypertension in Adults
Volume 155, Issue 1, Pages (January 2019)
Efficacy and Safety of Bevacizumab-Based Therapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer in the Phase III.
Volume 152, Issue 6, Pages (December 2017)
Bedside Calibration Of Pulmonary Artery Catheters
Interaction of Rifampin and Glyburide
Volume 150, Issue 4, Pages (October 2016)
Gavin C. Harewood, MD, FRCPI, MSc  Gastrointestinal Endoscopy 
Use of Endobronchial Ultrasound for Bedside Diagnosis of Acute Pulmonary Embolism in a Critically Ill Patient  Colleen L. Channick, MD, FCCP, Richard.
Presentation transcript:

Volume 154, Issue 6, Pages 1371-1378 (December 2018) Health-care Cost Impact of Continued Anticoagulation With Rivaroxaban vs Aspirin for Prevention of Recurrent Symptomatic VTE in the EINSTEIN-CHOICE Trial Population  Philip S. Wells, MD, Martin H. Prins, MD, Jan Beyer-Westendorf, MD, Anthonie W.A. Lensing, MD, PhD, Lloyd Haskell, MD, Bennett Levitan, MD, PhD, François Laliberté, MA, Veronica Ashton, MPH, Yongling Xiao, PhD, Dominique Lejeune, MSc, Concetta Crivera, PharmD, MPH, Patrick Lefebvre, MA, Qi Zhao, MD, MPH, Zhong Yuan, MD, PhD, Jeff Schein, DrPH, MPH, Paolo Prandoni, MD, PhD  CHEST  Volume 154, Issue 6, Pages 1371-1378 (December 2018) DOI: 10.1016/j.chest.2018.08.1059 Copyright © 2018 The Authors Terms and Conditions

Figure 1 Per patient per month costs for 12 months of extended anticoagulation therapy following initial 6 to 12 months of anticoagulation therapy for patients with VTE. Numbers have been rounded. CHEST 2018 154, 1371-1378DOI: (10.1016/j.chest.2018.08.1059) Copyright © 2018 The Authors Terms and Conditions

Figure 2 Per patient per month costs for 12 months of extended anticoagulation therapy following initial 6 to 12 months of anticoagulation therapy for patients with VTE, with 15% rivaroxaban discount. Numbers have been rounded. CHEST 2018 154, 1371-1378DOI: (10.1016/j.chest.2018.08.1059) Copyright © 2018 The Authors Terms and Conditions

Figure 3 Total health-care cost difference between patients treated with rivaroxaban 10 mg and patients treated with aspirin, estimated by one-way sensitivity analysis of input parameters. PE = pulmonary embolism. CHEST 2018 154, 1371-1378DOI: (10.1016/j.chest.2018.08.1059) Copyright © 2018 The Authors Terms and Conditions

Figure 4 Total health-care cost difference between patients treated with rivaroxaban 10 mg and patients treated with aspirin, estimated by one-way sensitivity analysis of input parameters, with 15% rivaroxaban discount. See Figure 3 legend for expansion of abbreviation. CHEST 2018 154, 1371-1378DOI: (10.1016/j.chest.2018.08.1059) Copyright © 2018 The Authors Terms and Conditions